S-1: Spectral AI Files for Resale of Up to 6.4 Million Shares of Common Stock

Spectral AI has filed a registration statement for the resale of up to 6,369,937 shares of its common stock by YA II PN, LTD (Yorkville).

Summary

• Spectral AI has filed a Form S-1 registration statement for the resale of up to 6,369,937 shares of its common stock.
• The shares are to be sold by YA II PN, LTD (Yorkville), the selling stockholder.
• These shares include up to 6,275,000 purchase shares that Spectral AI may elect to sell to Yorkville under a standby equity purchase agreement (SEPA) and 94,937 commitment shares already issued to Yorkville.
• Spectral AI will not receive any proceeds from the resale of shares by Yorkville, but may receive up to $30 million in gross proceeds from sales of common stock to Yorkville under the SEPA.
• The company intends to use any proceeds received from such sales to Yorkville for working capital and general corporate purposes.
• The purchase price for shares sold to Yorkville under the SEPA will be 97% of the lowest daily VWAP during the three consecutive trading days commencing on the date of the delivery of the Advance Notice.
• Yorkville may also convert Promissory Notes into shares of the Company's Common Stock at any time at a fixed conversion price equal to (i) in respect of the Promissory Note issued in connection with the first Pre -Paid Advance, $3.16, and (ii) in respect of the Promissory Notes issued in connection with the second and third Pre -Paid Advances, a price per share equal to 120% of the average of the daily VWAPs during the three consecutive trading days immediately preceding the issuance date of each Promissory Note.
• The company is limited in the number of shares it can issue to Yorkville under Nasdaq rules, not to exceed 19.99% of the outstanding shares immediately prior to the SEPA execution (the Exchange Cap), unless stockholder approval is obtained or the average price per share equals or exceeds $2.37.
• Yorkville is also subject to a beneficial ownership limitation of 4.99% of the outstanding shares of Spectral AI's common stock.
• As of April 8, 2024, Spectral AI had 17,561,808 shares of common stock outstanding.

Sentiment

Score: 6

Explanation: The document is neutral in tone, primarily outlining the terms of a financial agreement. While the potential for dilution is a concern, the access to capital is a positive aspect.

Positives

• Spectral AI has access to a potential $30 million in funding through the SEPA with Yorkville.
• The company retains control over the timing and amount of any sales of common stock to Yorkville under the SEPA.
• The SEPA does not impose restrictions on future financings, rights of first refusal, participation rights, penalties, or liquidated damages.

Negatives

• The issuance of common stock to Yorkville will dilute the economic and voting interests of existing stockholders.
• The market price of Spectral AI's common stock could be negatively impacted by sales of a substantial number of shares by Yorkville.
• The company's management has broad discretion over the use of the net proceeds from the sale of shares to Yorkville.

Risks

• The actual number of shares sold under the SEPA and the resulting gross proceeds are uncertain.
• Investors who buy shares at different times will likely pay different prices.
• Sales of a substantial number of securities in the public market by existing stockholders could cause the price of the shares of Common Stock to fall.
• The management team will have broad discretion over the use of the net proceeds from the sale of shares of Common Stock to Yorkville, if any, and you may not agree with how we use the proceeds and the proceeds may not be invested successfully.

Future Outlook

Spectral AI expects that any proceeds received from sales to Yorkville will be used for working capital and general corporate purposes.

Industry Context

This announcement reflects a common financing strategy for companies seeking capital, particularly in the biotech and medical device sectors, where ongoing research and development require significant funding.

Comparison to Industry Standards

• Comparable companies in the medical device and AI space often utilize equity purchase agreements to secure funding.
• The terms of the SEPA, including the discount to VWAP and commitment shares, are generally consistent with industry standards for such agreements.

Stakeholder Impact

• Existing shareholders will experience dilution of their economic and voting interests.
• The company will have access to additional capital to fund its operations.
• The market price of the company's common stock may be negatively impacted by sales of shares by Yorkville.

Next Steps

• Spectral AI may elect to sell shares of common stock to Yorkville under the SEPA.
• Yorkville may resell the shares of common stock in the public market.
• Spectral AI may need to obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap.
• Spectral AI may need to file additional registration statements to register additional shares of common stock for resale by Yorkville.

Key Dates

Keywords

Spectral AI, YA II PN, LTD, Yorkville, SEPA, Common Stock, Resale, Equity Financing, Dilution, Prospectus, Registration Statement